NANoREG D5 04 DR In vitro screening methodology to evaluate toxicity by inhalation Acesse: https://www.rivm.nl/en/documenten/nanoreg-d5-04-dr-in-vitro-screening-methodology-to-evaluate-toxicity-by-inhalation
NANoREG D5 04 DR In vitro screening methodology to evaluate toxicity by inhalation
NANoREG D6.02 DR Inventory of safety assessment issues and new approaches to research and governance
NANoREG D2.10 SOP 01 Preparation of EM-grids containing a representative sample of a dispersed NM
NANoREG D1 08 DR Case study summary report including feasibility check of the proposed answers
NANoREG D3.01 DR Gap analysis report, identifying the critical exposure scenarios within the key value chains
NANoREG D5.07 SOP 05 Viability protocol by using a Cell Counter
https://www.rivm.nl/documenten/nanoreg-d507-sop-05-viability-protocol-by-using-a-cell-counter
NANoREG D5.07 SOP 06 HEL16T008 AlamarBlue Assay
https://www.rivm.nl/documenten/nanoreg-d507-sop-06-hel16t008-alamarblue-assay
